Research.Patient.info

Glycosphingolipid lysosomal storage disorders research hub

2 indexed studies · 0 currently recruiting

ongoing, recruitingHuman Pharmacology (Phase I)- Other
AZ-3102: Protocol AZA-001-31-02: An open-label, single-dose phase 1 study to evaluate the Absorption, Metabolism, and Excretion of [14C]-AZ-3102 in Healthy Male Subjects
This early-stage study is looking at a new medicine called AZ-3102. It's for a group of conditions called glycosphingolipid lysosomal storage disorders. We want to see how the body takes in, breaks down, and gets rid of this medicine in healthy men.
Netherlands
ongoing, recruitingHuman Pharmacology (Phase I)- Other
A PHASE I, OPEN-LABEL, RANDOMIZED, ADAPTIVE, CROSS-OVER STUDY TO DETERMINE THE RELATIVE BIOAVAILABILITY OF NIZUBAGLUSTAT CAPSULES COMPARED TO ORALLY DISPERSIBLE TABLETS AND THE FOOD EFFECT IN HEALTHY VOLUNTEERS
This study is looking at how well a new medicine, nizubaglustat, is absorbed by the body. It compares two forms: capsules and tablets that dissolve in your mouth. We also check if food changes how the medicine works in healthy volunteers.
Netherlands